arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Balance Labs, Inc.

BLNC
— Price unavailable
Industrials ·Services-Management Consulting Services ·USServices-Management Consulting Services
49 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
52
Health
Fair
Bullish
auto_awesome

Analytical Summary

Balance Labs, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC 14.3% ↗
FCF / Share $-0.00 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

49-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$7.33K
↓ -77.6% —
Net Income Profit after all expenses
$177.80K
— 0.0% —
Operating Margin Operating profit as % of sales
-44.2%
↓ -170.0% —
FCF / Share Free cash flow per share
$-0.00
↑ +30.6% —
Long-Term Debt Long-term obligations
$25.00K
↓ -95.2% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Financial Health ↑
66
Cash Quality ↓
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 12 years · 49 quarters